NCT02695537: University of Alabama at Birmingham (UAB) Pediatric CBD Program
- State
- Completed
- Phase
- Phase 1
- People
- 89 taking part
- Started
- Apr 2015
- Primary completion
- 27 Feb 2019
- Arms
- Epidiolex 100 milligram/milliliter (mg/mL) oral solution
- Results
- Posted on the registry
- Papers
- doi:10.1016/j.yebeh.2019.03.042, doi:10.1080/13554794.2017.1391294
- 1 Mar 2016: Trial registered
- 27 Feb 2019: Trial completed
- 10 Apr 2020: Trial results posted